Skip to main content
Top
Published in: Infection 3/2019

01-06-2019 | Tuberculosis | Review

Latent tuberculosis infection in transplant candidates: a systematic review and meta-analysis on TST and IGRA

Authors: Mohammad Javad Nasiri, Ali Pormohammad, Hossein Goudarzi, Masoud Mardani, Samin Zamani, Giovanni Battista Migliori, Giovanni Sotgiu

Published in: Infection | Issue 3/2019

Login to get access

Abstract

Introduction

The diagnostic accuracy of interferon-gamma release assays (IGRAs) and the tuberculin skin test (TST) for latent tuberculosis infection (LTBI) in transplant candidates is uncertain.

Methods

Pubmed, Embase and Cochrane library were searched to identify relevant studies. Quality of included studies was assessed with RevMan5 software (via GUADAS2 checklist). Accuracy measures of IGRAs and TST assays (sensitivity, specificity and others) were pooled with random effects model. Data were analyzed by STATA and Meta-DiSc.

Results

Twenty-eight studies were selected for full review, and 16 were included in the final analysis. The pooled sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), positive likelihood ratio (PLR), negative likelihood ratio (NLR) and diagnostic odds ratio (DOR) for TST were 46% [95% confidence interval (CI) 38–54%], 86% (95% CI 75–93%), 46.3% (95% CI 40–52), 88.7% (95% CI 87–89), 3.3 (95% CI 1.6–6.4), 0.63 (95% CI 0.52–0.77) and 5 (95% CI 2–12), respectively. For QFT-G, the pooled sensitivity, specificity, PPV, NPV, PLR, NLR, and DOR were 58% (95% CI 41–73%), 89% (95% CI 77–95%), 72.7% (95% CI 68–76), 80.6% (95% CI 78–82), 5.3 (95% CI 2.0–14.0), 0.47 (95% CI 0.30–0.75) and 11 (95% CI 3–46), respectively. Likewise, for T-SPOT.TB, the pooled sensitivity, specificity, PPV, NPV, PLR, NLR, and DOR were 55% (95% CI 40–70%), 92% (95% CI 87–95%), 60.4% (95% CI 47–72), 90.2% (95% CI 86–92), 6.7 (95% CI 4.0–11.1), 0.52 (95% CI 0.31–0.85) and 16 (95% CI 7–37), respectively.

Conclusions

IGRAs were more sensitive and specific than the TST with regard to the diagnosis of LTBI in the transplant candidates. They have added value and can be complementary to TST.

Literature
  1. Getahun H, et al. Latent Mycobacterium tuberculosis infection. N Engl J Med. 2015;372:2127–35.View ArticlePubMed
  2. World Health Organization. Global Tuberculosis Report 2018. Geneva: WHO; 2018. Available from: http://​www.​who.​int/​tb/​publications/​global_​report/​en/​. Accessed 6 Dec 2018.
  3. Getahun H, et al. Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries. Eur Respir J. 2015;46:1563–76.View ArticlePubMedPubMed Central
  4. Migliori GB, et al., ERS/ECDC statement: European Union standards for tuberculosis care-2017 update. Eur Respir J. 2018;51:1702678.View ArticlePubMed
  5. Munoz P, Rodriguez C, Bouza E. Mycobacterium tuberculosis infection in recipients of solid organ transplants. Clin Infect Dis. 2005;40:581–7.View ArticlePubMed
  6. Singh N, Paterson DL. Mycobacterium tuberculosis infection in solid-organ transplant recipients: impact and implications for management. Clin Infect Dis. 1998;27:1266–77.View ArticlePubMed
  7. Horsburgh CR Jr. Priorities for the treatment of latent tuberculosis infection in the United States. N Engl J Med. 2004;350:2060–7.View ArticlePubMed
  8. Sester M, et al. Risk assessment of tuberculosis in immunocompromised patients. A TBNET study. Am J Respir Crit Care Med. 2014;190:1168–76.View ArticlePubMed
  9. Subramanian A, Dorman S. Mycobacterium tuberculosis in solid organ transplant recipients. Am J Transpl. 2009;9:S57–62.View Article
  10. Muñoz P, Rodríguez C, Bouza E. Mycobacterium tuberculosis infection in recipients of solid organ transplants. Clin Infect Dis. 2005;40:581–7.View ArticlePubMed
  11. Jasmer RM, Nahid P, Hopewell PC. Latent tuberculosis infection. N Engl J Med. 2002;347:1860–6.View ArticlePubMed
  12. Sester M, et al. Interferon-γ release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis. Eur Respir J. 2011;37:100–11.View ArticlePubMed
  13. Ferguson TW, et al. The diagnostic accuracy of tests for latent tuberculosis infection in hemodialysis patients: a systematic review and meta-analysis. Transplantation. 2015;99:1084–91.View ArticlePubMed
  14. Rogerson TE, et al. Tests for latent tuberculosis in people with ESRD: a systematic review. Am J Kidney Dis. 2013;61:33–43.View ArticlePubMed
  15. Cattamanchi A, et al. Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals—a systematic review and meta-analysis (1999). J Acquir Immune Defic Syndr. 2011;56:230.View ArticlePubMedPubMed Central
  16. Chang KC, Leung CC. Systematic review of interferon-gamma release assays in tuberculosis: focus on likelihood ratios. Thorax. 2010;65:271–6.View ArticlePubMed
  17. Redelman-Sidi G, Sepkowitz KA. IFN-γ release assays in the diagnosis of latent tuberculosis infection among immunocompromised adults. Am J Respir Crit Care Med. 2013;188:422–31.View ArticlePubMed
  18. Diel R, et al. Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur Respir J. 2011;37:88–99.View ArticlePubMed
  19. Whiting PF, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155:529–36.View ArticlePubMed
  20. Glas AS, et al. The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol. 2003;56:1129–35.View ArticlePubMed
  21. Higgins J, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58.View ArticlePubMed
  22. Deeks JJ, Macaskill P, Irwig L. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol. 2005;58:882–93.View ArticlePubMed
  23. Manuel O, et al. Comparison of quantiferon-TB gold with tuberculin skin test for detecting latent tuberculosis infection prior to liver transplantation. Am J Transpl. 2007;7:2797–801.View Article
  24. Kim SH, et al. Diagnostic usefulness of a T cell-based assay for latent tuberculosis infection in kidney transplant candidates before transplantation. Transpl Infect Dis. 2010;12:113–9.View ArticlePubMed
  25. Ahmadinejad Z, et al. QuantiFERON-TB Gold In-Tube test for diagnosis of latent tuberculosis (TB) infection in solid organ transplant candidates: a single-center study in an area endemic for TB. Transpl Infect Dis. 2013;15:90–5.View ArticlePubMed
  26. Mansour AE, et al. Utility of QuantiFERON-TB Gold In-Tube testing in the detection of latent tuberculosis in liver transplant candidates. Egypt Liver J. 2012;2:67–71.View Article
  27. Theodoropoulos N, et al. Use of the QuantiFERON-TB Gold interferon-gamma release assay for screening transplant candidates: a single-center retrospective study. Transpl Infect Dis. 2012;14:1–8.View ArticlePubMed
  28. Lindemann M, et al. Diagnosis of tuberculosis infection in patients awaiting liver transplantation. Hum Immunol. 2009;70:24–8.View ArticlePubMed
  29. Casas S, et al. Comparison of the 2-step tuberculin skin test and the quantiFERON-TB Gold In-Tube Test for the screening of tuberculosis infection before liver transplantation. Liver Transpl. 2011;17:1205–11.View ArticlePubMed
  30. Kim JS, et al. Comparison of QuantiFERON-TB Gold with tuberculin skin test for detection of latent tuberculosis infection before kidney transplantation. Transpl Proc. 2013;45:2899–902.View Article
  31. Jafri SM, et al. Detection and management of latent tuberculosis in liver transplant patients. Liver Transpl. 2011;17:306–14.View ArticlePubMed
  32. Edathodu J, et al., Diagnostic potential of interferon-gamma release assay to detect latent tuberculosis infection in kidney transplant recipients. Transpl Infect Dis, 2017. 19:e12675.View Article
  33. Mardani M, et al. Performance of QuantiFERON TB gold test compared with the tuberculin skin test for detecting latent tuberculosis infection in lung and heart transplant candidates. Exp Clin Transpl. 2014;12:129–32.
  34. Moon SM, et al. Comparison of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection prior to hematopoietic stem cell transplantation. Transpl Infect Dis. 2013;15:104–9.View ArticlePubMed
  35. Qin LL, et al. T-SPOT.TB for detection of tuberculosis infection among hematological malignancy patients and hematopoietic stem cell transplant recipients. Asian Pac J Cancer Prev. 2013;14:7415–9.View ArticlePubMed
  36. Richeldi L, et al. Performance of tests for latent tuberculosis in different groups of immunocompromised patients. Chest. 2009;136:198–204.View ArticlePubMed
  37. Sherkat R, et al. Concordance of the tuberculin skin test and T-SPOT((R)).TB test results in kidney transplant candidates. J Res Med Sci. 2014;19:S26-9.PubMed
  38. Simkins J, Kraus K, Morris MI. Demographics and prevalence of positive QuantiFERON-TB Gold In-Tube test in renal transplant candidates. Transpl Infect Dis. 2016;18:5–13.View ArticlePubMed
  39. Roth PJ, et al. Serial testing for latent tuberculosis infection in transplant candidates: a retrospective review. Transpl Infect Dis. 2016;18:14–21.View ArticlePubMed
  40. Sayyahfar S, et al. Comparison of tuberculin skin test and interferon gamma release assay for diagnosis of latent tuberculosis infection in pediatric candidates of renal transplantation. Pediatr Transpl. 2018;22:e13148.View Article
  41. Aguado JM, et al. Tuberculosis in solid-organ transplant recipients: consensus statement of the group for the study of infection in transplant recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology. Clin Infect Dis. 2009;48:1276–84.View ArticlePubMed
  42. Pai M, Menzies D. Interferon-γ release assays: what is their role in the diagnosis of active tuberculosis? Clin Infect Dis. 2007;44:74–7.View ArticlePubMed
  43. Jones S, et al. Utility of QuantiFERON-TB Gold in-tube testing for latent TB infection in HIV-infected individuals. Int J Tuberc Lung Dis. 2007;11:1190–5.PubMed
  44. Mardani M, et al. Performance of QuantiFERON-TB Gold test compared to tuberculin skin test in detecting latent tuberculosis infection in HIV-positive individuals in Iran. Ann Thorac Med. 2010;5:43.View ArticlePubMedPubMed Central
  45. Blumberg HM, Leonard MK, Jasmer RM. Update on the treatment of tuberculosis and latent tuberculosis infection. JAMA. 2005;293:2776–84.View ArticlePubMed
  46. Bumbacea D, et al. The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement. Eur Respir J. 2012;40:990–1013.View ArticlePubMed
  47. Nienhaus A, et al. Systematic review of cost and cost-effectiveness of different TB-screening strategies. BMC Health Serv Res. 2011;11:247.View ArticlePubMedPubMed Central
  48. De Keyser E, De Keyser F, De Baets F. Tuberculin skin test versus interferon-gamma release assays for the diagnosis of tuberculosis infection. Acta Clin Belgica. 2014;69:358–66.View Article
  49. Wang L, et al. A meta-analysis of the effect of Bacille Calmette Guerin vaccination on tuberculin skin test measurements. Thorax. 2002;57:804–9.View ArticlePubMedPubMed Central
  50. Manuel O, Kumar D. QuantiFERON®-TB Gold assay for the diagnosis of latent tuberculosis infection. Expert Rev Mol Diagn. 2008;8:247–56.View ArticlePubMed
  51. Mazurek GH, et al. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection-United States, 2010. MMWR Recomm Rep. 2010;59:1–25.PubMed
Metadata
Title
Latent tuberculosis infection in transplant candidates: a systematic review and meta-analysis on TST and IGRA
Authors
Mohammad Javad Nasiri
Ali Pormohammad
Hossein Goudarzi
Masoud Mardani
Samin Zamani
Giovanni Battista Migliori
Giovanni Sotgiu
Publication date
01-06-2019
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 3/2019
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-019-01285-7

Other articles of this Issue 3/2019

Infection 3/2019 Go to the issue